Dermatofibrosarcoma protuberans: Two rare variants
Sir, In the March-April 2019 issue of Indian Journal of Dermatology, Venereology and Leprology, Jain et al. described two rare variants of dermatofibrosarcoma protuberans in two Indian patients. 1 It is explicit that various skin disorders are common and cause significant morbidity in individuals infected with human immunodeficiency virus (HIV) and these are often more severe, atypical, and more difficult to treat in comparison to dermatoses in the immunocompetent individuals. Therefore, dermatological examination, laboratory tests, and skin biopsy for histopathological study are essential for sound diagnostic workup of HIV-related mucocutaneous diseases, considering that an atypical picture occurs in a large proportion of the patients. 2 In the light of susceptibility of HIV-infected patients to develop dermatofibrosarcoma protuberans, 3 on one hand, and substantial HIV seroprevalence of 0.26% in India (compared with a global average of 0.2%), 4 on the other hand, the contribution of HIV infection to the development of the rare variants would have to be taken into consideration. Hence, ideally. HIV testing and the associated workup of blood CD4 lymphocyte count and viral load measurements would have to be envisaged in the two cases in question.
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Author's reply
Sir, I would like to thank you for your interest in our case of two rare variants of dermatofibrosarcoma protuberans.
You have rightly pointed out that there is an increased prevalence of this condition in HIV seropositive cases.
1 However, case 1 described in the letter to the editor had persistent slowly progressive lesion since the past 25 years with no history suggestive of HIV seropositivity occurring before the appearance of lesion and progression of the same over the period of 25 years. 2 You have also rightly stated that the incidence of HIV seroprevalence in India is higher than global average. 3 However, the case in discussion hails from Madhya Pradesh which is a low prevalence state for HIV. 4 Prevalence of HIV seropositivity in blood donors in the state of Madhya Pradesh was found to be 0.10%, which is lower than the global average (0.2%). 4 In view of the above factors, HIV testing was not undertaken. We agree with the argument that HIV testing must be done in cases of atypical cases of dermatofibrosarcoma protuberans especially in areas of high prevalence of HIV.
